Phase I Trial of Vaccination With Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 and Lymphotactin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I Trial of Vaccination With Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 and Lymphotactin

Published:2007-02 Issue:2 Volume:30 Page:227-233
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Russell Heidi V.,Strother Douglas,Mei Zhuyong,Rill Donna,Popek Edwina,Biagi Ettore,Yvon Eric,Brenner Malcolm,Rousseau Raphael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference17 articles.

1. Combined chemokine and cytokine gene transfer enhances antitumor immunity;Dilloo;Nat Med,1996

2. Vaccine therapies for pediatric malignancies;Rousseau;Cancer J,2005

3. IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma;Bowman;Blood,1998

4. Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma;Bowman;Hum Gene Ther,1998

5. Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma;Rousseau;Blood,2003

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future of Clinical Trials and Application of Precision Medicine;Pediatric Oncology;2024

2. Advances in pharmacotherapy for neuroblastoma;Expert Opinion on Pharmacotherapy;2021-07-26

3. The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology;European Journal of Cancer;2021-02

4. Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment;Cancers;2021-01-23

5. Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells;Pharmaceutics;2020-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3